The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
Salute e medicinaIAOne-Off3a
Manifold MarketsSenza KYCDati di risoluzione verificatiDiscretamente calibratoAvviso sulla qualità dei datiDati obsoleti
Dati al 26 ott 2026, 16:37 UTC · criterio pm-quality-4
Previsione della comunità attuale
No 73.6%
No 73.6%Previsori
113
Tipo di domanda
binary
Metodologia
Play-money forecasting platform
Tipo di fonte
Previsione
Dati di mercato
Aggiornato ieri
Obsoleto21 dic 22, 17:45 UTC31 dic 29, 23:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Will FDA approve an “AI doctor” for primary care before 2030?
Manifold MarketsWill the FDA approve VERVE-102?
KalshiThe FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
Manifold MarketsWill the FDA approve Viagra as a treatment for Alzheimer's before 2030?
Manifold MarketsWill the FDA approve a fully autonomous robotic surgery device before 2030?
Manifold MarketsWill the FDA approve a cure for Type 1 diabetes before 2033?
KalshiRegole
The drug company will credit key steps of the discovery or steps in the treatment process to AI/ML techniques.
- The treatment must be approved before 2030 by the FDA for a condition afflicting at least 1 million people at the time, which had no previous cure, rarely goes into remission, and without treatment either significantly shortens lifespan or is considered extremely debilitating.
- Treatments may exist at the time, but this will be a complete cure with an efficacy of >50%.
- The treatment may need to be repeated if the illness recurs, but isn't needed on a continuing basis.
- Examples (not limited to):
- An incurable virus, bacterium, or parasite.
